Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Apotel for postoperative pain after total knee arthroplasty
IRCT20220812055663N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in knee arthritis and postoperative pain comparing Remifentanil arm with Apotel (intravenous acetaminophen) arm (2 arms). Primary endpoint: postoperative pain intensity. Started Sep 2022; status: completed.
02
Drugs
remifentanilacetaminophen
03
Conditions
knee arthritispostoperative pain
Beyond the preview
Go deeper on IRCT20220812055663N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220812055663N1.